biotech - search results
If you're not happy with the results, please do another search
Why This Pullback Is Better (and Worse) Than It Seems
US stocks seem like they've been split in two by the current pullback. Or is it 4? The number depends entirely on what segment...
S&P 500 Sector Analysis: A Harmonic Deconstruction
The S&P 500 revisited and lapsed beneath December/January resistance near 1850 last Friday, briefly wobbling back into negative territory on the year before aggressively...
Chartology: XLB, XLV, IBB, ISIS, GILD, BAC, SCTY, MSFT, EUR/USD
Here's a small slice of those charts I'm looking at as another trading week wraps up.
Market Cap Relative Strength
Relative strength across market capitalization remains...
The Best Of See It Market – February 2014
Investors dedicated most of the month of February to offsetting January's equities drubbing. It seems that bearish sentiment has been sensitive and tends to...
Chartology: IBB, SPY, ISIS, SOX, AAPL, BAC, USDJPY, GLD
As today's session closes out on the benchmark S&P 500 (SPX) as an indecisive spinning top candlestick with bulls failing to press yesterday's attainment...
Investing ETFs To Watch For Global Deflationary Signals
The stock market has been pretty choppy to begin the New Year. Could this be a deflationary signal? Stocks have see-sawed up and down...
22 Charts Say Be Open To Bullish Stock Market Resolution
Charts allow us to monitor the never-ending battle between bullish economic conviction and bearish economic conviction. Experienced traders know higher beta and more economically...
Silent Running: How the Dow Transports Outperform
By Andrew Kassen The Dow Transports outperform; but just don't get much play.
Once referred to simply as the "Rails" because of the historic prevalence...
Not So Far East: A Macro Economic Look at Southeast Asia
By Jeff Wilson
After a terrific article by Alex Salomon on the deep-seeded cultural and economic issues facing France, I would like to take you to...
High-Tech Pharmacal (HITK) Sizzling; What to Expect Now
By Joshua Schroeder
High-Tech Pharmacal (HITK) is a small cap biotech/pharmaceutical stock that I added to my portfolio in July and August and then recommended on...